Stock Analiz

SS Innovations International, Inc. SSII

Medical/Dental Instruments · data as of November 13, 2026

$1.66Market cap $333M
Open the interactive analysis →

SS Innovations International, Inc. (SSII) is a healthcare company listed in the US with a market value of about $333M. In the twelve months to June 30, 2026 it had revenue of $52M and net income of -$12M, a net margin of -23.7%.

Its overall Stock Analiz score is 1.2 out of 5 (weak). The strongest part is future growth (4/5); the weakest is value (0/5).

Key numbers: a 5-year average ROIC of -50%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 90% below the current price.

About SS Innovations International

SS Innovations International is listed in the US and classified in medical/dental instruments. Revenue went from $1M in 2022 to $42M in 2025, growth of about 209.3% a year. It was profitable in 0 of the last 10 years in our data. Its share count rose by 55% over three years (dilution for shareholders). It spends 9% of revenue on research and development.

Score: 1.2 / 5

Value0/5
Future growth4/5
Track record0/5
Financial health2/5
Shareholder returns0/5

Checks passed

  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving
  • Strong R&D investment or growth above 20%
  • More cash than debt, or low debt to equity
  • Liabilities below 60% of assets

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year
  • 5-year revenue growth above 8% a year

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S6.4
P/B6.2
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-5.5%
Shareholder yield0.0%
Intrinsic value vs. price−90%

Growth and quality

Revenue growth (1 yr)105.7%
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-175.1%
ROIC (5-yr avg.)-49.6%
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 10 years

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$52M$42M$21M$6M$1M——————
Net income-$12M-$12M-$19M-$21M-$3M-$1M-$1M-$3M-$960322-$1M-$484982
Free cash flow-$18M-$22M-$10M-$16M-$6M——-$424227———
EPS (diluted)$-0.06$-0.06$-0.11$-0.14$-0.03$-0.05$-0.05$-0.16$-0.05$-0.05$-0.03
Net margin-23.7%-28.5%-92.7%-355.4%-223.8%——————
ROIC—-15.7%-63.3%-69.7%———————

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

What analysts expect

The average 12-month price target from 1 analysts is $7.00, 322% above the current price; targets range from $7.00 to $7.00; the consensus rating is “none”; expected EPS is $-0.06 for the fiscal year ending December 31, 2026.

Frequently asked questions

Is SS Innovations International stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 90% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does SS Innovations International pay a dividend?

Not currently.

Is SS Innovations International a good stock to buy?

We do not give buy or sell advice. SS Innovations International scores 1.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.